10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2016 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 14, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Cash flows from operating activities: | |||
| Net income | $ 7,722 | 6,939 | 5,158 |
| Depreciation and amortization | 2,105 | 2,108 | 2,092 |
| Stock-based compensation expense | 311 | 322 | 408 |
| Deferred income taxes | 183 | (607) | (108) |
| Other items, net | 32 | (146) | 56 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (214) | (420) | 136 |
| Inventories | (80) | 481 | 327 |
| Other assets | (128) | 155 | (1) |
| Accounts payable | (44) | (12) | 228 |
| Accrued income taxes | (301) | 509 | (103) |
| Other liabilities | 768 | 402 | 759 |
| Net cash provided by operating activities | 10,354 | 9,731 | 8,952 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (738) | (594) | (718) |
| Cash paid for acquisitions, net of cash acquired | 0 | (359) | (165) |
| Purchases of intangible assets | (99) | (55) | (285) |
| Purchases of marketable securities | (28,094) | (25,977) | (25,878) |
| Proceeds from sales of marketable securities | 17,958 | 18,029 | 16,697 |
| Proceeds from maturities of marketable securities | 2,459 | 3,527 | 4,199 |
| Proceeds from sale of property, plant and equipment | 78 | 274 | 3 |
| Change in restricted investments, net | 0 | 0 | 533 |
| Other | (222) | (392) | (138) |
| Net cash used in investing activities | (8,658) | (5,547) | (5,752) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 7,318 | 3,465 | 4,476 |
| Repayment of debt | (3,725) | (2,400) | (5,605) |
| Repurchases of common stock | (2,965) | (1,867) | (138) |
| Dividends paid | (2,998) | (2,396) | (1,851) |
| Net proceeds from issuance of common stock in connection with the Companys equity award programs | 55 | 82 | 186 |
| Settlement of contingent consideration obligations | 0 | (253) | (92) |
| Withholding taxes arising from shares withheld for share-based payments | (260) | (401) | (225) |
| Other | (24) | (1) | (25) |
| Net cash used in financing activities | (2,599) | (3,771) | (3,274) |
| (Decrease) increase in cash and cash equivalents | (903) | 413 | (74) |
| Cash and cash equivalents at beginning of period | 4,144 | 3,731 | |
| Cash and cash equivalents at end of period | 3,241 | 4,144 | 3,731 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |